Close Menu

This week in PNAS, researchers describe their ultrahigh-throughput screening platform that uses drop-based microfluidics to overcome the limitations of traditional methods employed to measure biochemical reactions. The team applied their method ― which uses "aqueous drops dispersed in oil as picoliter-volume reaction vessels" ― to directed evolution; they identified novel mutants of enzymes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.